1. Home
  2. FVRR vs NERV Comparison

FVRR vs NERV Comparison

Compare FVRR & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fiverr International Ltd. no par value

FVRR

Fiverr International Ltd. no par value

HOLD

Current Price

$11.53

Market Cap

372.4M

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$6.26

Market Cap

301.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FVRR
NERV
Founded
2010
2007
Country
Israel
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
372.4M
301.6M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
FVRR
NERV
Price
$11.53
$6.26
Analyst Decision
Buy
Buy
Analyst Count
9
2
Target Price
$18.43
$10.50
AVG Volume (30 Days)
879.5K
180.1K
Earning Date
04-29-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.83
N/A
P/E Ratio
$22.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.67
$1.30
52 Week High
$34.13
$12.46

Technical Indicators

Market Signals
Indicator
FVRR
NERV
Relative Strength Index (RSI) 56.40 48.40
Support Level $9.97 $5.83
Resistance Level $17.34 $6.69
Average True Range (ATR) 0.59 0.51
MACD 0.17 -0.03
Stochastic Oscillator 47.91 22.94

Price Performance

Historical Comparison
FVRR
NERV

About FVRR Fiverr International Ltd. no par value

Fiverr International Ltd operates a online marketplace that enables sellers to offer digital services and buyers to purchase them The Company's platform features an extensive catalog of digital services that spans over hundreds of categories. Buyers can purchase digital services ranging from simple services such as logo design and blog post writing, to complex services such as video creation, website development and social media marketing. Also, the Company offers value-added services including subscription products, advertising solutions and financial tools designed to support marketplace users and enhance their business activities. The company generates maximum of its revenue from USA.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: